Products

What will AGI do for Amikacin sulfate?

This classification denotes an aminoglycoside antibiotic with the molecular formula C22H43N5O13.2H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N6M33094FD, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1->4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)- but more generally known as amikacin sulfate, which bears US NIH Compound Identifier 37768. The base compound, Amikacin, most often comes in dihydrate, disulfate, hydrate, and sulfate forms. European Medicines Agency schedules Amikacin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00444MIG. Most nations, for tariff and trade purposes, schedule amikacin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, AMIKACIN SULFATE remains US FDA's Preferred Term for this commodity. Amikacin sulfate bears US NLM identifiers UMLS ID C0700949 and NCI Concept Code C230. SMILES: C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O.